跳至主要内容
临床试验/NCT06227572
NCT06227572招募中不适用

Cognition After Obstructive Sleep Apnea (OSA) Treatment Among Native American People (CATNAP)

Washington State University2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2025年2月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
140
试验地点
2
主要终点
Nights of PAP use

研究概览

简要总结

This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).

详细描述

The investigators will develop a multilevel 9-month culturally informed motivational interviewing and electronic messaging intervention- "Cognition After Obstructive Sleep Apnea (OSA) Among Native American People" (CATNAP) to: 1) provide participants with Motivational Interviewing sessions to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias (ADRD) in American Indians and 2) provide participants with electronic messaging to support PAP adherence among American Indian elders, aged 50 years and older.

This study will explore the relationship between OSA and cognitive function and evaluate OSA as a mechanism for the strong association between sleep disorders and Alzheimer's disease and related dementias (ADRD). CATNAP will be implemented as a randomized controlled trial at 4 community sites serving American Indians in the Northern Plains. A total of 300 American Indian elders, aged 50 years and older, with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP component (intervention condition).

The primary outcome is PAP adherence and secondary outcome cognitive function. The study will partner with Missouri Breaks Industries Research Inc., and Missouri Breaks Durable Medical Equipment to monitor participants PAP use, which is uploaded automatically to the cloud. Outcomes will be measured at baseline, 3-months, and 9-months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50 years and older
  • Self report American Indian or Alaskan Native
  • diagnosed with obstructive sleep apnea
  • prescribed PAP therapy and have a device
  • *Ability to understand written and spoken English; and
  • *Ability and willingness to follow all study protocols.

排除标准

  • Living in a household with someone who is enrolled in the study
  • Already using PAP device at Medicaid recommended standards
  • Cognitive decline, unable to consent on their own

研究组 & 干预措施

Intervention Group

Experimental

The CATNAP MI intervention consists of 3 Motivational Interviewing sessions to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias (ADRD) in American Indians and electronic messaging to support PAP adherence, and usual care. Data will be collected at baseline, 3-months, and 9-months.

干预措施: CATNAP MI (Behavioral)

Waitlist Control Group

No Intervention

Usual care, consisting of an in-service on how to operate the PAP machine, and a mask fitting to select the most comfortable, effective mask for the individual. After 4-6 weeks of use, the participant will be contacted by Missouri Breaks Durable Medical Equipment to review objective adherence data and address any challenges or barriers to therapy such as treatment-emergent central apneas. Data will be collected at baseline, 3-months, and 9-months.

结局指标

主要结局

Nights of PAP use

时间窗: 9 months

Proportion of nights with 4+ hours of PAP use from PAP device

Positive Airway Pressure (PAP) minutes per night

时间窗: 9 months

Participant mask-on time data collected by the PAP equipment will be extracted as continuous minutes per night.

PAP adherence

时间窗: 9-months

Use of device for more than 240 minutes per night, on 21 or more days out of the past 30 days. From PAP device.

次要结局

  • Cognivue total score(9 months)
  • Montreal Cognitive Assessment total score(9 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Denise Dillard

Professor

Washington State University

研究点 (2)

Loading locations...

相似试验

Cognition After OSA Treatment Among Native American... | 临床试验